⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Drug Delivery Devices Market Set to Exceed US$ 450.7 Billion by 2035 as Biologic Revenue Surges Drive Urgent Expansion of Device Manufacturing Capacity Says Astute Analytica
globenewswire.com
LLY
NVO
BDX
WST
STZ
DrMedHealth.com Launches Nationwide GLP-1 Medical Weight Loss Program with Board-Certified Physicians
accessnewswire.com
LLY
NVO
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
globenewswire.com
VRTX
NVO
CRSP
Form Health Simplifies GLP-1 Coverage Opportunities for Employers with Transparent, Predictable Pricing
businesswire.com
LLY
NVO
Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss
globenewswire.com
NVO
Cadonilimab (PD-1/CTLA-4) Receives FDA Clearance for Global Phase III First-Line Gastric Cancer Trial Versus Nivolumab
prnewswire.com
NVO
ShedRx GLP-1 Platform: Pricing, Process, and What Consumers Should Know Before Starting Telehealth Weight Loss
accessnewswire.com
NVO
LLY
Amid Escalating Market Investment, Physicians Forecast Rapid Uptake of Oral Semaglutide Upon Approval in Obesity, According to Spherix Global Insights
globenewswire.com
NVO
LLY
Europe $7.4 Bn Insulin Pen Market Opportunities, Growth Drivers, Industry Trend Analysis, and Forecasts 2025-2034
globenewswire.com
LLY
MDT
NVO
SNY
BDX
North America $9.2 Bn Insulin Pen Market Opportunities, Growth Drivers, Industry Trend Analysis, and Forecasts 2025-2034
globenewswire.com
BDX
LLY
MDT
NVO
SNY